The SMID premium problem
Two years of consolidation have moderated small- and midcap (SMID) valuations from their peak, and still left them expensive on almost every measure that has history attached.
The median SMID stock trades at 38× trailing earnings, against a 46× peak in 2024 and a long-run average of 20×. For scale: this multiple was 20× at the 2007 top, 10× at the 2013 bottom, and 15× in the 2020 COVID trough. Today’s “corrected” level remains roughly double the average of the past two decades. (Data: Bloomberg, DSP; as of July 2026.)
Against large caps:
| Measure, April 2026 | Large caps | Their LT average | SMIDs | Their LT average |
|---|---|---|---|---|
| Trailing price-to-book | 3.4 | 3.6 | 4.0 | 2.8 |
| 1-year forward P/E | 19 | 17 | 24 | 18 |
| Premium to large caps (fwd P/E) | — | — | 27% | 5% |
Data: Nuvama, DSP; as of April 2026.
Large caps trade slightly below their own price-to-book history; SMIDs trade ~43% above theirs, and at a 27% forward-P/E premium to large caps against a 5% historical norm. The large-cap cohort also carries better ROEs for a similar earnings trajectory.
The margin-of-safety data tells the same story from the bottom up: 33% of SMIDs trade below 3× book value today. That is better than the 23% of August 2024, and far from the 70% seen during the COVID trough. Cheapness is a minority condition in the segment. (Data: Capitaline, DSP; as of 31 July 2026.)
None of this forecasts that SMIDs must fall. Premiums can persist, and in this correction the segment has so far avoided the deep underperformance typical of downcycles. But paying twice the historical multiple for the median smaller company, in a market where broad earnings growth is capped near nominal GDP, leaves the outcome leaning on the premium sustaining itself.
What we’ll watch: whether the SMID-to-large-cap forward premium narrows toward its 5% norm, through prices, earnings, or both, and whether the below-3×-book share keeps rising.